Header cover image
  • Investing Ideas
  • Taiwanese Pharmaceuticals & Biotech High Return On Equity, Low Debt

Taiwanese Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Center Laboratories

Market Cap: NT$27.8b

Center Laboratories, Inc. ist ein pharmazeutisches Unternehmen, das Arzneimittel in Taiwan und international entwickelt, herstellt und vertreibt.

4123

NT$37.20

7D

-1.2%

1Y

3.7%